Applied dna announces pricing of $12 million upsized public offering, priced at a premium to market under nasdaq rules

Stony brook, n.y.--(business wire)---- $apdn #lineardna--applied dna sciences, inc., (nasdaq: apdn) (the “company” or “applied dna”), a leader in polymerase chain reaction ("pcr")-based technologies, today announced the pricing of a public offering of 3,000,000 shares of its common stock (or common stock equivalents in lieu thereof), together with series a warrants to purchase up to 3,000,000 shares of its common stock and series b warrants to purchase up to 3,000,000 shares of its common stock at a combined offeri
APDN Ratings Summary
APDN Quant Ranking